PSYREFLECT

All Articles

402 analyses · page 9 of 17

  1. Industry95% never get the right treatment: the IOCDF OCD care-crisis report and what it means for parity in 2026
  2. IndustryAASM 2025: when CBT-I meets a sleeping pill, the pill is the one that loses
  3. ResearchFamily-Based CBT Beats Active Control in Paediatric OCD — But the Margin Is Smaller Than We Like to Say
  4. ResearchBipolar II maintenance: the evidence base for lithium and lamotrigine is thinner than the guidelines suggest
  5. ResourceBTTI 2026: Where Clinicians Actually Learn to Run ERP for OCD
  6. ToolWAI-SR + TFI Cohesiveness in telehealth groups: a minimal two-scale process kit
  7. ResearchOne Question About Suicidality, 9.5 Years of Mortality: What a Korean National Cohort Tells Us
  8. ResearchOne Dose of LSD for Generalised Anxiety: What the JAMA Phase 2b Actually Showed
  9. ToolPBS-5: a five-item screen for non-substance addictive behaviours, anchored to ICD-11
  10. ResourceCIIS Psychedelic-Assisted Therapies Certificate: 2026-2027 Cohort Now Open
  11. IndustryAustralia's Authorised Prescriber Scheme: What 134 Patients Reveal About a Real-World Psychedelic Programme
  12. IndustryIndia's Tele-MANAS at year three: 3.4 million calls, 53 cells, and the unfinished business of the treatment gap
  13. ResearchA System Fix, Not a Therapist Fix: How Mozambique Closed Its MNS Care Gaps by 46 Points
  14. ToolThe ETMCQ-R: 18 Items to Know Whether Your Patient Can Actually Learn from You
  15. IndustryCMS 2026 Fee Schedule: Solo Therapists Get a Flat Rate, Integrated Practices Get +3.77%
  16. IndustryRussia's Mental Health System Redraws Its Boundaries: Two 2026 Orders That Every Practitioner Needs to Know
  17. ResearchTherapeutic Alliance With an AI Chatbot Predicts Outcomes the Same Way It Does With Humans
  18. ResourceThe Bowlby Centre's Attachment Certificate: A Year of Saturdays That Pays Off
  19. IndustryRejoyn at 24 months — what the first FDA-authorised prescription DTx for depression actually did to the market
  20. ToolPassive smartphone sensing as a between-session clinical instrument
  21. ResearchCluster-C Personality Disorders Cost €27K–€60K Per Patient Per Year — and We Keep Overlooking Them
  22. ResourceInternal Family Systems Level 1 in 2026 — the training track that is not CBT or EMDR
  23. IndustryAnxiety and Trauma Disorders Nearly Doubled Among US Older Adults in a Decade — State System Data, n=4.2M
  24. ResearchAmygdala neurofeedback for PTSD moves from trial into community clinic